Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark.

arXiv:2606.30170v2 Announce Type: replace-cross Abstract: Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but lim